Cargando…

Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study

PURPOSE: Neoadjuvant radiotherapy (NeoRT) improves tumor local control and facilitates tumor resection in many cancers. Some clinical studies demonstrated that both timing of surgery and RT schedule influence tumor dissemination, and subsequently patient overall survival. Previously, we developed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lallemand, François, Leroi, Natacha, Blacher, Silvia, Bahri, Mohamed Ali, Balteau, Evelyne, Coucke, Philippe, Noël, Agnès, Plenevaux, Alain, Martinive, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724034/
https://www.ncbi.nlm.nih.gov/pubmed/34993143
http://dx.doi.org/10.3389/fonc.2021.784437
_version_ 1784625838458667008
author Lallemand, François
Leroi, Natacha
Blacher, Silvia
Bahri, Mohamed Ali
Balteau, Evelyne
Coucke, Philippe
Noël, Agnès
Plenevaux, Alain
Martinive, Philippe
author_facet Lallemand, François
Leroi, Natacha
Blacher, Silvia
Bahri, Mohamed Ali
Balteau, Evelyne
Coucke, Philippe
Noël, Agnès
Plenevaux, Alain
Martinive, Philippe
author_sort Lallemand, François
collection PubMed
description PURPOSE: Neoadjuvant radiotherapy (NeoRT) improves tumor local control and facilitates tumor resection in many cancers. Some clinical studies demonstrated that both timing of surgery and RT schedule influence tumor dissemination, and subsequently patient overall survival. Previously, we developed a pre-clinical model demonstrating the impact of NeoRT schedule and timing of surgery on metastatic spreading. We report on the impact of NeoRT on tumor microenvironment by MRI. METHODS: According to our NeoRT model, MDA-MB 231 cells were implanted in the flank of SCID mice. Tumors were locally irradiated (PXI X-Rad SmART) with 2x5Gy and then surgically removed at different time points after RT. Diffusion-weighted (DW) and Dynamic contrast enhancement (DCE) MRI images were acquired before RT and every 2 days between RT and surgery. IntraVoxel Incoherent Motion (IVIM) analysis was used to obtain information on intravascular diffusion, related to perfusion (F: perfusion factor) and subsequently tumor vessels perfusion. For DCE-MRI, we performed semi-quantitative analyses. RESULTS: With this experimental model, a significant and transient increase of the perfusion factor F [50% of the basal value (n=16, p<0.005)] was observed on day 6 after irradiation as well as a significant increase of the WashinSlope with DCE-MRI at day 6 (n=13, p<0.05). Using immunohistochemistry, a significant increase of perfused vessels was highlighted, corresponding to the increase of perfusion in MRI at this same time point. Moreover, Tumor surgical resection during this peak of vascularization results in an increase of metastasis burden (n=10, p<0.05). CONCLUSION: Significant differences in perfusion-related parameters (F and WashinSlope) were observed on day 6 in a neoadjuvant radiotherapy model using SCID mice. These modifications are correlated with an increase of perfused vessels in histological analysis and also with an increase of metastasis spreading after the surgical procedure. This experimental observation could potentially result in a way to personalize treatment, by modulating the time of surgery guided on MRI functional data, especially tumor perfusion.
format Online
Article
Text
id pubmed-8724034
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87240342022-01-05 Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study Lallemand, François Leroi, Natacha Blacher, Silvia Bahri, Mohamed Ali Balteau, Evelyne Coucke, Philippe Noël, Agnès Plenevaux, Alain Martinive, Philippe Front Oncol Oncology PURPOSE: Neoadjuvant radiotherapy (NeoRT) improves tumor local control and facilitates tumor resection in many cancers. Some clinical studies demonstrated that both timing of surgery and RT schedule influence tumor dissemination, and subsequently patient overall survival. Previously, we developed a pre-clinical model demonstrating the impact of NeoRT schedule and timing of surgery on metastatic spreading. We report on the impact of NeoRT on tumor microenvironment by MRI. METHODS: According to our NeoRT model, MDA-MB 231 cells were implanted in the flank of SCID mice. Tumors were locally irradiated (PXI X-Rad SmART) with 2x5Gy and then surgically removed at different time points after RT. Diffusion-weighted (DW) and Dynamic contrast enhancement (DCE) MRI images were acquired before RT and every 2 days between RT and surgery. IntraVoxel Incoherent Motion (IVIM) analysis was used to obtain information on intravascular diffusion, related to perfusion (F: perfusion factor) and subsequently tumor vessels perfusion. For DCE-MRI, we performed semi-quantitative analyses. RESULTS: With this experimental model, a significant and transient increase of the perfusion factor F [50% of the basal value (n=16, p<0.005)] was observed on day 6 after irradiation as well as a significant increase of the WashinSlope with DCE-MRI at day 6 (n=13, p<0.05). Using immunohistochemistry, a significant increase of perfused vessels was highlighted, corresponding to the increase of perfusion in MRI at this same time point. Moreover, Tumor surgical resection during this peak of vascularization results in an increase of metastasis burden (n=10, p<0.05). CONCLUSION: Significant differences in perfusion-related parameters (F and WashinSlope) were observed on day 6 in a neoadjuvant radiotherapy model using SCID mice. These modifications are correlated with an increase of perfused vessels in histological analysis and also with an increase of metastasis spreading after the surgical procedure. This experimental observation could potentially result in a way to personalize treatment, by modulating the time of surgery guided on MRI functional data, especially tumor perfusion. Frontiers Media S.A. 2021-12-21 /pmc/articles/PMC8724034/ /pubmed/34993143 http://dx.doi.org/10.3389/fonc.2021.784437 Text en Copyright © 2021 Lallemand, Leroi, Blacher, Bahri, Balteau, Coucke, Noël, Plenevaux and Martinive https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Lallemand, François
Leroi, Natacha
Blacher, Silvia
Bahri, Mohamed Ali
Balteau, Evelyne
Coucke, Philippe
Noël, Agnès
Plenevaux, Alain
Martinive, Philippe
Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study
title Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study
title_full Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study
title_fullStr Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study
title_full_unstemmed Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study
title_short Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study
title_sort tumor microenvironment modifications recorded with ivim perfusion analysis and dce-mri after neoadjuvant radiotherapy: a preclinical study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724034/
https://www.ncbi.nlm.nih.gov/pubmed/34993143
http://dx.doi.org/10.3389/fonc.2021.784437
work_keys_str_mv AT lallemandfrancois tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy
AT leroinatacha tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy
AT blachersilvia tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy
AT bahrimohamedali tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy
AT balteauevelyne tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy
AT couckephilippe tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy
AT noelagnes tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy
AT plenevauxalain tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy
AT martinivephilippe tumormicroenvironmentmodificationsrecordedwithivimperfusionanalysisanddcemriafterneoadjuvantradiotherapyapreclinicalstudy